Application of plasma alternative to serum for measuring leucine-rich α2-glycoprotein as a biomarker of inflammatory bowel disease

BACKGROUND: Inflammatory bowel disease (IBD) is a chronic intestinal disorder characterized by recurrent flare-ups and remission. Leucine-rich α2-glycoprotein (LRG) has been developed as a new serum biomarker of disease activity in patients with IBD. However, there have been no reports on whether pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Ichimiya, Tadashi, Kazama, Tomoe, Ishigami, Keisuke, Yokoyama, Yoshihiro, Hayashi, Yuki, Takahashi, Satoshi, Itoi, Takao, Nakase, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289387/
https://www.ncbi.nlm.nih.gov/pubmed/37352151
http://dx.doi.org/10.1371/journal.pone.0286415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10289387/
https://www.ncbi.nlm.nih.gov/pubmed/37352151
http://dx.doi.org/10.1371/journal.pone.0286415

Ejemplares similares